It was also previously shown that inhibiting FABP5 expression in mice abrogates pulmonary artery remodeling and improves heart function in left heart disease-associated pulmonary hypertension, and silencing FABP5 attenuates the TGF-β1-induced fibrosis response in cultured PAFs43. Here, TGFB1 is linked to pulmonary hypertension.